Proteomika. Biomarcadores para el diagnóstico no invasivo de enfermedades complejas.

  1. Home
  2. Orders


Img promonitor



Promonitor® is a product developed by Progenika and distributed worlwide. 

Please contact your local distributor to place an order.

 Promonitor pict

  • Highly specific ELISA kits (96 wells)
  • Quantification of serum drug levels and anti-drug antibodies
  • Full validation in serum according to CLSI guidelines
  • Precoated, ready-to-use, convenient assays in 2h 30 min
  • Clinically validated in gastroenterology, rheumatology and dermatology
  • Cut-points and interpretation of results
  • Convenient software for automated data analysis, interpretation of results and reporting
  • Manufactured under ISO13485 in GMP-compliant facilities

pdf Download brochure

Promonitor® kits IVD Reference RUO Reference
Promonitor-IFX (infliximab levels)*  5060230000  5060130000
Promonitor-Anti-IFX (anti-infliximab antibody levels)*  5070230000  5070130000
Promonitor-ADL (adalimumab levels)  5080230000  5080130000
Promonitor-Anti-ADL (anti-adalimumab antibody levels)  5090230000  5090130000
Promonitor-ETN (etanercept levels)*  5110230000  5110130000
Promonitor-Anti-ETN (anti-etanercept antibody levels)  5120230000  5120130000
Promonitor-RTX (rituximab levels)*  5130230000  5130130000
Promonitor-Anti-RTX (anti-rituximab antibody levels)  5140230000  5140130000
Promonitor-GLM (golimumab levels)  5200230000  5200130000
Promonitor-Anti-GLM (anti-golimumab antibody levels)  5210230000  5210130000
Promonitor-VDZ (vedolizumab)  5391530000  5391430000
Promonitor-Anti-VDZ (anti-vedolizumab antibody levels)  5401530000  5401430000
Promonitor-UTK (ustekinumab levels) In validation  53714300DV
Promonitor-Anti-UTK (anti-ustekinumab antibody levels) In validation  53814300DV
*Promonitor-IFX (Refs. 5060230000/5060130000) and Promonitor-Anti-IFX (Refs. 5070230000/5070130000) are valid to monitor drug levels and anti-drug antibody levels of any biological drug which contains the active substance infliximab; that is the reference medicine Remicade® and any biosimilar drug like CT-P13 (Remsima® or Inflectra®) and SB2 (Flixabi®). Promonitor-RTX (5130230000/5130130000) is valid to monitor either the reference rituximab (MabThera®) or the biosimilar CT-P10 (Truxima®). Promonitor-ETN (Refs. 5110230000/5110130000) is valid to monitor drug levels of any biological drug which contains the active substance etanercept; that is the reference medicine Enbrel® and any biosimilar drug like SB4 (Benepali®) and Erelzi®. 

Diagnostic Service

Drug and anti-drug antibody levels are also available as a Diagnostic Service. Patient samples for testing are collected according to a standard protocols and sent to Proteomika for analysis. Sample analysis is performed by trained personnel in authorized facilities. The referring clinic receives a detailed report via e-mail presenting patient-specific information on circulating drug levels and immune response to treatment in the context of clinical studies allowing easy interpretation of the test results.

pdfOrder Form

pdfExample of Report


pdf Promonitor local distributors